ClinConnect ClinConnect Logo
Search / Trial NCT05694494

Training- and Cost-effectiveness of an Internet-based Lifestyle-integrated Functional Exercise Program (iLiFE)

Launched by CHINESE UNIVERSITY OF HONG KONG · Jan 12, 2023

Trial Information

Current as of May 22, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

All subjects will then be randomly assigned to receive either an internet-based therapist-led LiFE program with a home environment safety assessment (iLiFE) or attention control intervention. Randomization into block groups of four in a 1:1 ratio (the iLiFE group or the attention control group) will be generated in a password-protected excel file by independent research personnel not involved in data collection or intervention after the baseline assessment. The randomization will be concealed by the independent personnel. Research assistants who are blinded to the group allocation will cond...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged ≥ 65 years,
  • community-dwelling,
  • have a fall history in the previous 12 months,
  • have a moderate or above risk of falls as assessed by the Physiological Profile Assessment (total z-score ≥ 1)
  • can ambulate on level surfaces without physical contact of another person as assessed by Functional Ambulation Category (score ≥ 3)
  • cognitively intact as assessed by the Hong Kong version of the Montreal Cognitive Assessment-5-minute protocol (score ≥ 16th percentile of the age and education-adjusted cut-off score)
  • able to communicate effectively.
  • Exclusion Criteria:
  • uncorrected vision or hearing impairment,
  • unstable medical condition that may preclude the planned exercises, and
  • have been receiving or planning to receive any fall prevention program within the study period.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Timothy Kwok

Principal Investigator

The Chinese Univsersity of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials